Abstract
The aim of this guideline is to provide standards for the recommendation, performance, interpretation and reporting of Ga-68-PSMA PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of Ga-68-PSMA PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.
Original language | English |
---|---|
Pages (from-to) | 1014-1024 |
Number of pages | 11 |
Journal | European Journal of Nuclear Medicine and Molecular Imaging |
Volume | 44 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2017 |
Keywords
- PSMA
- PET
- Prostate cancer
- Staging
- Restaging
- Guideline
- MEMBRANE ANTIGEN-EXPRESSION
- TUMOR-ASSOCIATED NEOVASCULATURE
- GA-68-LABELED PSMA LIGAND
- RENAL-CELL CARCINOMA
- RADIATION-DOSIMETRY
- RADIOLIGAND THERAPY
- HBED-CC
- ANDROGEN RECEPTOR
- BIODISTRIBUTION
- INHIBITOR